Charlotte's Web Holdings (CWBHF) Cash from Investing Activities (2021 - 2026)
Charlotte's Web Holdings (CWBHF) posted quarterly Cash from Investing Activities of -$17000.0 for Q1 2026, up 96.55% year-over-year from -$8649.1 in Q1 2025, and down 114.66% quarter-over-quarter from $116000.0 in Q4 2025.
Charlotte's Web Holdings (CWBHF) Cash from Investing Activities (2021 - 2026) Analysis & Trends
Charlotte's Web Holdings (CWBHF) has reported Cash from Investing Activities for 6 consecutive years, with -$17000.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Cash from Investing Activities rose 96.55% year-over-year to -$17000.0; the TTM figure through Mar 2026 stood at $64000.0 (up 102.84% YoY), while the FY2025 annual figure was -$412000.0, up 89.15% from the prior year.
- Cash from Investing Activities slipped to -$17000.0 in Q1 2026 per CWBHF's latest filing, from $116000.0 in the prior quarter.
- Across five years, Cash from Investing Activities topped out at $452000.0 in Q4 2022 and bottomed at -$2.7 million in Q3 2023.
- Historically, Cash from Investing Activities has averaged -$431529.4 across 5 years, with a median of -$111000.0 in 2023.
- Annual changes were most pronounced in 2022 — Cash from Investing Activities jumped 164.66% — and 2024, when it tumbled 4982.5%.
- Charlotte's Web Holdings' Cash from Investing Activities stood at $452000.0 in 2022, then slumped by 234.96% to -$610000.0 in 2023, then soared by 67.54% to -$198000.0 in 2024, then surged by 158.59% to $116000.0 in 2025, then plunged by 114.66% to -$17000.0 in 2026.
- Business Quant data shows CWBHF's Cash from Investing Activities at -$17000.0 in Q1 2026, $116000.0 in Q4 2025, and $11000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.87 Bn | 42.91 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.00 Bn | 39.35 Bn | 2.15 Bn | -491.00 Mn |
| 3 | Zoetis | 31.59 Bn | 29.92 Bn | 1.05 Bn | -300.00 Mn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | -550.24 Mn |
| 5 | United Therapeutics | 22.15 Bn | 19.49 Bn | 683.80 Mn | 87.50 Mn |
| 6 | Viatris | 18.74 Bn | 17.85 Bn | 1.46 Bn | -51.60 Mn |
| 7 | Neurocrine Biosciences | 15.55 Bn | 15.16 Bn | 935.80 Mn | -135.40 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | -110.00 Mn |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.96 Bn | - | - |
| 10 | Charlotte's Web Holdings | 63.58 Mn | 49.59 Mn | 5.16 Mn | -28,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -28,000.00 |
| Jun 30, 2026 | -28,000.00 |
| Mar 31, 2026 | -17,000.00 |
| Mar 31, 2026 | -17,000.00 |
| Dec 31, 2025 | 116,000.00 |
| Dec 31, 2025 | 116,000.00 |
| Sep 30, 2025 | 11,000.00 |
| Sep 30, 2025 | 11,000.00 |
| Jun 30, 2025 | -46,000.00 |
| Jun 30, 2025 | -46,000.00 |
| Mar 31, 2025 | -493,000.00 |
| Mar 31, 2025 | -493,000.00 |
| Dec 31, 2024 | -198,000.00 |
| Dec 31, 2024 | -198,000.00 |
| Sep 30, 2024 | -310,000.00 |
| Sep 30, 2024 | -310,000.00 |
| Jun 30, 2024 | -1.26 Mn |
| Jun 30, 2024 | -1.26 Mn |
| Mar 31, 2024 | -2.03 Mn |
| Mar 31, 2024 | -2.03 Mn |